This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

Preoperative -Blockade and Risk of Postoperative Atrial Fibrillation

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their study on the effect of preoperative -blocker therapy on coronary artery bypass graft (CABG) surgery outcomes, Dr Ferguson and colleagues¹ did not address its effect on the incidence of postoperative atrial fibrillation (AF). Atrial fibrillation has been reported in 5% to 40% of patients undergoing CABG,² is associated with increased length of hospital stay³ and increased incidence of perioperative stroke,⁴ and generally occurs 2 to 3 days after CABG and seldom earlier.⁵ Although a meta-analysis of randomized controlled trials in 1991 showed that prophylactic -blocker therapy had a protective effect against the development of postoperative AF,⁶ its routine preoperative use is still not universally adopted. Furthermore, it would be interesting to know if the trend toward a decrease in stroke that Ferguson et al observed among patients treated with -blockers was due to a decreased incidence of postoperative AF.

Tsung O. Cheng, MD
Department of . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Preoperative -Blocker Use and Mortality and Morbidity Following CABG Surgery in North America
T. Bruce Ferguson, Jr, Laura P. Coombs, Eric D. Peterson, and for the Society of Thoracic Surgeons National Adult Cardiac Surgery Database
JAMA. 2002;287(17):2221-2227.
ABSTRACT | FULL TEXT